Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing.

Bjurlin MA, Carter HB, Schellhammer P, Cookson MS, Gomella LG, Troyer D, Wheeler TM, Schlossberg S, Penson DF, Taneja SS.

J Urol. 2013 Jun;189(6):2039-46. doi: 10.1016/j.juro.2013.02.072. Epub 2013 Feb 26. Review.

2.

Standards for prostate biopsy.

Bjurlin MA, Taneja SS.

Curr Opin Urol. 2014 Mar;24(2):155-61. doi: 10.1097/MOU.0000000000000031. Review.

3.

Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.

Gallina A, Maccagnano C, Suardi N, Capitanio U, Abdollah F, Raber M, Salonia A, Scattoni V, Rigatti P, Montorsi F, Briganti A.

BJU Int. 2012 Jul;110(2 Pt 2):E64-8. doi: 10.1111/j.1464-410X.2011.10762.x. Epub 2011 Nov 17.

4.

Does site specific labeling of sextant biopsy cores predict the site of extracapsular extension in radical prostatectomy surgical specimen.

Taneja SS, Penson DF, Epelbaum A, Handler T, Lepor H.

J Urol. 1999 Oct;162(4):1352-7; discussion 1357-8.

PMID:
10492195
5.
6.

Optimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assessment.

Bjurlin MA, Meng X, Le Nobin J, Wysock JS, Lepor H, Rosenkrantz AB, Taneja SS.

J Urol. 2014 Sep;192(3):648-58. doi: 10.1016/j.juro.2014.03.117. Epub 2014 Apr 21. Review.

7.

Prediction of pathological and oncological outcomes based on extended prostate biopsy results in patients with prostate cancer receiving radical prostatectomy: a single institution study.

Ishizaki F, Hara N, Koike H, Kawaguchi M, Tadokoro A, Takizawa I, Nishiyama T, Takahashi K, Hohenfellner R.

Diagn Pathol. 2012 Jun 14;7:68.

8.

The number of cores taken in patients diagnosed with a single microfocus at initial biopsy is a major predictor of insignificant prostate cancer.

Villa L, Capitanio U, Briganti A, Abdollah F, Suardi N, Salonia A, Gallina A, Freschi M, Russo A, Castiglione F, Bianchi M, Rigatti P, Montorsi F, Scattoni V.

J Urol. 2013 Mar;189(3):854-9. doi: 10.1016/j.juro.2012.09.100. Epub 2012 Sep 25.

PMID:
23022004
9.

Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care.

Ukimura O, Coleman JA, de la Taille A, Emberton M, Epstein JI, Freedland SJ, Giannarini G, Kibel AS, Montironi R, Ploussard G, Roobol MJ, Scattoni V, Jones JS.

Eur Urol. 2013 Feb;63(2):214-30. doi: 10.1016/j.eururo.2012.09.033. Epub 2012 Sep 25. Review.

PMID:
23021971
10.

Prostate sampling by 12-core biopsy: comparison of the biopsy results with tumor location in prostatectomy specimens.

Iremashvili V, Pelaez L, Jorda M, Manoharan M, Arianayagam M, Rosenberg DL, Soloway MS.

Urology. 2012 Jan;79(1):37-42. doi: 10.1016/j.urology.2011.09.011. Epub 2011 Nov 4.

PMID:
22055691
11.

How accurate is our clinical prediction of "minimal prostate cancer"?

Leibovici D, Shikanov S, Gofrit ON, Zagaja GP, Shilo Y, Shalhav AL.

Isr Med Assoc J. 2013 Jul;15(7):359-63.

12.

The potential impact of prostate volume in the planning of optimal number of cores in the systematic transperineal prostate biopsy.

Ficarra V, Novella G, Novara G, Galfano A, Pea M, Martignoni G, Artibani W.

Eur Urol. 2005 Dec;48(6):932-7. Epub 2005 Sep 16.

PMID:
16202510
13.
14.
15.

Six additional systematic lateral cores enhance sextant biopsy prediction of pathological features at radical prostatectomy.

Singh H, Canto EI, Shariat SF, Kadmon D, Miles BJ, Wheeler TM, Slawin KM.

J Urol. 2004 Jan;171(1):204-9.

PMID:
14665877
16.

Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.

King CR, McNeal JE, Gill H, Presti JC Jr.

Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):386-91.

PMID:
15145152
17.

The relationship between tumor volume and the number of positive cores in men undergoing multisite extended biopsy: implication for expectant management.

Ochiai A, Troncoso P, Chen ME, Lloreta J, Babaian RJ.

J Urol. 2005 Dec;174(6):2164-8, discussion 2168.

PMID:
16280756
18.

Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.

Stewart CS, Leibovich BC, Weaver AL, Lieber MM.

J Urol. 2001 Jul;166(1):86-91; discussion 91-2.

PMID:
11435830
19.

Sampling of the anterior apical region results in increased cancer detection and upgrading in transrectal repeat saturation biopsy of the prostate.

Seles M, Gutschi T, Mayrhofer K, Fischereder K, Ehrlich G, Gallé G, Gutschi S, Pachernegg O, Pummer K, Augustin H.

BJU Int. 2016 Apr;117(4):592-7. doi: 10.1111/bju.13108. Epub 2015 May 14.

20.

Sextant prostate biopsies predict side and sextant site of extracapsular extension of prostate cancer.

Elliott SP, Shinohara K, Logan SL, Carroll PR.

J Urol. 2002 Jul;168(1):105-9.

PMID:
12050501

Supplemental Content

Support Center